DCG-IV

DCG-IV is a research drug which acts as a group-selective agonist for the group II metabotropic glutamate receptors (mGluR2/3). It has potent neuroprotective and anticonvulsant effects in animal studies,   as well as showing anti-Parkinsonian effects,  but also impairs the formation of memories.